glutathione kills triple negative cancer

glutathione kills triple negative cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione responsive nanomedicine leverages tumor

Name: glutathione kills triple negative cancer Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Therapy Glutathione responsive nanomedicine leverages tumor
Brand: equiscorp.hu
SKU: 72492726360
Price: 20.57 USD
Availability: InStock
Rating: 4.0657 (23 reviews)

Glutathione responsive nanomedicine leverages tumor redox imbalance for targeted cancer theranostics Discover Oncology Springer Nature Link Tumor targeted glutathione oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Nature Communications Frontiers Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple negative breast cancer GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect

SKU: 72492726360 · From equiscorp.hu

4.1

USD20.57 USD55.57

Pay in 4 interest-free payments of $5.14 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

It steals hormones needed for fertility

Compared with other metabolites, endogenous reactive species facilitate the efficient functioning of biochemical processes, and their specialization ensures the coordinated and orderly integration of distinct pathways

Gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain and the CNS, is necessary for illness prevention, information processing, neuronal activity, and healthy brain growth